I
Ivan Papić
Researcher at Josip Juraj Strossmayer University of Osijek
Publications - 13
Citations - 91
Ivan Papić is an academic researcher from Josip Juraj Strossmayer University of Osijek. The author has contributed to research in topics: Random walk & Internal medicine. The author has an hindex of 3, co-authored 9 publications receiving 29 citations.
Papers
More filters
Journal ArticleDOI
Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis
Marko Lucijanic,Tomislav Čikara,Petra Bistrovic,Ivan Papić,Maja Ortner Hadžiabdić,Nikolina Busic,Marina Lacković,Natália Reigota César,Valentina Košćak,Joško Mitrović,Bruno Baršić,Tomo Lucijanić +11 more
TL;DR: Yoon et al. as discussed by the authors showed that remdesivir treatment might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease, which is a favorable side effect.
Journal ArticleDOI
Heavy-tailed fractional Pearson diffusions
TL;DR: Heavy-tailed fractional reciprocal gamma and Fisher-Snedecor diffusions are defined by a non-Markovian time change in the corresponding Pearson diffusions and strong solutions of the associated Cauchy problems for the fractional backward Kolmogorov equation are derived.
Journal ArticleDOI
The associations of age, sex, and comorbidities with survival of hospitalized patients with coronavirus disease 2019: data from 4014 patients from a tertiary-center registry
Nevenka Piskac Zivkovic,Marko Lucijanic,Nikolina Busic,Ivana Jurin,Armin Atic,Ana Andrilovic,Toni Penović,Iva Domić,Jelena Gnjidić,Martina Demaria,Ivan Papić,Ida Tješić-Drinković,Ivica Lukšić,Bruno Baršić +13 more
TL;DR: Among younger patients, female sex might lead to an adverse prognosis due to undisclosed reasons (differences in fat tissue distribution, hormonal status, and other mechanisms).
Journal ArticleDOI
A two diffusion stochastic model for the spread of the new corona virus SARS-CoV-2.
TL;DR: In this paper, a refined version of the stochastic SEIR model for epidemic of the new corona virus SARS-Cov-2, causing the COVID-19 disease, was proposed.